Discovery of anticancer agents of diverse natural origin

被引:71
作者
Kinghorn, A. Douglas [1 ]
de Blanco, Esperanza J. Carcache [1 ]
Chail, Hee-Byung [1 ]
Orjala, Jimmy [2 ]
Farnsworth, Norman R. [2 ]
Soejarto, D. Doel [2 ]
Oberlies, Nicholas H. [3 ]
Wani, Mansukh C. [3 ]
Kroll, David J. [3 ]
Pearce, Cedric J. [4 ]
Swanson, Steven M. [2 ]
Kramer, Robert A. [5 ]
Rose, William C. [5 ]
Fairchild, Craig R. [5 ]
Vite, Gregory D. [5 ]
Emanuel, Stuart [5 ]
Jarjoura, David [6 ]
Cope, Frederick O. [6 ]
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL 60612 USA
[3] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[4] Mycosynthetix Inc, Hillsborough, NC 27278 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
natural products; plants; cyanobacteria; fungi; anticancer activity; NF-KAPPA-B; PRODUCT-DERIVED COMPOUNDS; ENANTIOSELECTIVE SYNTHESIS; DRUG DISCOVERY; ACULEATIN-A; ROCAGLAMIDE DERIVATIVES; ABSOLUTE-CONFIGURATIONS; PROTEASOME INHIBITION; FUNGAL METABOLITE; CANCER;
D O I
10.1351/PAC-CON-08-10-16
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A collaborative multidisciplinary research project is described in which new natural product anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical plants, aquatic cyanobacteria, and filamentous fungi. Information is provided on how these organisms are collected and processed. The types of bioassays are indicated in which crude extracts of these acquisitions are tested. Progress made in the isolation of lead bioactive secondary metabolites from three tropical plants is discussed.
引用
收藏
页码:1051 / 1063
页数:13
相关论文
共 97 条
[31]   National cooperative drug discovery groups (NCDDGs): A successful model for public private partnerships in cancer drug discovery [J].
Hallock, YF ;
Cragg, GM .
PHARMACEUTICAL BIOLOGY, 2003, 41 :78-91
[32]   Alvaradoins A-D.: Anthracenone C arabinosides from Alvaradoa jamaicensis [J].
Harding, WW ;
Henry, GE ;
Lewis, PA ;
Jacobs, H ;
McLean, S ;
Reynolds, WF .
JOURNAL OF NATURAL PRODUCTS, 1999, 62 (01) :98-101
[33]  
HARIGAN G, 2000, SPECIAL PUBLICATION, V257, P126
[34]   THE FUNGAL DIMENSION OF BIODIVERSITY - MAGNITUDE, SIGNIFICANCE, AND CONSERVATION [J].
HAWKSWORTH, DL .
MYCOLOGICAL RESEARCH, 1991, 95 :641-655
[35]   Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum [J].
Heilmann, J ;
Brun, R ;
Mayr, S ;
Rali, T ;
Sticher, O .
PHYTOCHEMISTRY, 2001, 57 (08) :1281-1285
[36]  
HEILMANN J, 2000, HELV CHIM ACTA, V83, P1281
[37]  
Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO
[38]  
2-G
[39]   IN-VIVO CULTIVATION OF TUMOR-CELLS IN HOLLOW FIBERS [J].
HOLLINGSHEAD, MG ;
ALLEY, MC ;
CAMALIER, RF ;
ABBOTT, BJ ;
MAYO, JG ;
MALSPEIS, L ;
GREVER, MR .
LIFE SCIENCES, 1995, 57 (02) :131-141
[40]   Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. (vol 69, pg 3350, 2004) [J].
Hwang, BY ;
Su, BN ;
Chai, HB ;
Mi, QW ;
Kardono, LBS ;
Afriastini, JJ ;
Riswan, S ;
Santarsiero, BD ;
Mesecar, AD ;
Wild, R ;
Fairchild, CR ;
Vite, GD ;
Rose, WC ;
Farnsworth, NR ;
Cordell, GRA ;
Pezzuto, JM ;
Swanson, SM ;
Kinghorn, AD .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (18) :6156-6156